AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
PDF (919.5 KB)
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Publishing Language: Chinese | Open Access

Mechanisms and clinical significance of HIF-1α and EZH2 in acute myeloid leukemia

Jingmeng DING, Wanying CHENG, Xin ZHOU ( )
Department of Hematology, Wuxi People’s Hospital Affiliated to Nanjing Medical University (Wuxi Medical Center of Nanjing Medical University), Wuxi 214000, China
Show Author Information

Abstract

Acute myeloid leukemia (AML) is a highly heterogeneous and aggressive hematologic malignancy whose pathogenesis and progression are influenced by a variety of molecular mechanisms. These encompass genetic mutations, aberrant signaling pathways, epigenetic dysregulation, and complex interactions within the tumor microenvironment. Hypoxia-inducible factor-1α (HIF-1α), a master regulator of cellular response to low oxygen tension, is frequently overexpressed in AML, and its abnormal expression is closely associated with poor patient prognosis. The histone methyltransferase enhancer of zeste homolog 2 (EZH2), recognized as a high-risk molecular marker in the Chinese adult AML diagnosis and treatment guidelines, exhibits a context-dependent dual regulatory role. It can lose its tumor-suppressive function through loss-of-function mutations, while in specific disease stages, its overexpression contributes to maintaining leukemia stem cell properties and mediating chemotherapy resistance. Research indicates that HIF-1α and EZH2 may engage in synergistic crosstalk in AML, potentially forming a “metabolism-epigenetics” axis. This interaction creates a positive feedback loop that cooperatively promotes leukemia cell proliferation, blocks differentiation, facilitates metabolic reprogramming, and aids in immune evasion. This article provides a comprehensive review of the expression patterns, biological functions, interaction mechanisms, and clinical translational potential of HIF-1α and EZH2 in AML. The aim is to offer a theoretical foundation and suggest research directions for a deeper understanding of AML pathogenesis and the development of novel combination targeted therapy strategies.

CLC number: R733.71 Document code: A Article ID: 1007-4368(2026)06-945-08

References

【1】
【1】
 
 
Journal of Nanjing Medical University (Natural Sciences)
Pages 945-952

{{item.num}}

Comments on this article

Go to comment

< Back to all reports

Review Status: {{reviewData.commendedNum}} Commended , {{reviewData.revisionRequiredNum}} Revision Required , {{reviewData.notCommendedNum}} Not Commended Under Peer Review

Review Comment

Close
Close
Cite this article:
DING J, CHENG W, ZHOU X. Mechanisms and clinical significance of HIF-1α and EZH2 in acute myeloid leukemia. Journal of Nanjing Medical University (Natural Sciences), 2026, 46(6): 945-952. https://doi.org/10.7655/NYDXBNSN260018

2

Views

0

Downloads

0

Crossref

Received: 05 January 2026
Revised: 27 April 2026
Accepted: 09 May 2026
Published: 15 June 2026
© 2026 Editorial Board of Journal of Nanjing Medical University(Natural Sciences)

This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).